AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep-Wake Cycles in Rats

Overview

Journal Front Pharmacol

Date 2019 Aug 13

PMID 31404291

Citations 3

Authors

Emese Bogathy

Noemi Papp

Szilvia Vas

Gyorgy Bagdy

Laszlo Tothfalusi

Affiliations

Soon will be listed here.

Abstract

(a) To describe the microarchitecture of wakefulness and sleep following administrations of 5- and 10-mg/kg AM-251 in rats. (b) To develop a new statistical method to follow bout-to-bout dynamics. Wistar rats (n = 6) had been equipped with electroencephalography (EEG) and electromyography (EMG) electrodes. Following their recovery and habituation after the surgery, the animals were injected with vehicle and 5- and 10-mg/kg AM-251 intraperitoneally and EEG, EMG, and motor activity were analyzed for the subsequent 3 h. AM-251 induced a dose- and time-dependent increase in the number of bouts in active wake (AW), and it decreased this number in all other vigilance states except in passive wake (PW). In contrast, the bout duration in PW compensatory decreased. The effect of AM-251 on the sleep transition dynamics was monitored with a new tool we call "transition heatmap." The analysis of bout trajectories with transition heatmaps reveals a highly organized pattern. AM-251 selectively influences the frequency of vigilance state transitions, but it has no direct impact on the state lengths. AM-251 markedly changed the state transition dynamics, which was visualized with the help of state transition heatmaps.

Citing Articles

Systematic review/meta-analysis on the role of CB1R regulation in sleep-wake cycle in rats.

Xue J, Xu Z, Zhang J, Hou H, Ge L, Yang K J Evid Based Med. 2024; 17(4):714-728.

PMID: 39325651 PMC: 11684501. DOI: 10.1111/jebm.12643.

Evaluating Fatty Acid Amide Hydrolase as a Suitable Target for Sleep Promotion in a Transgenic TauP301S Mouse Model of Neurodegeneration.

Martin S, Joyce K, Harper K, Harp S, Cohen T, Moy S Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543105 PMC: 10975243. DOI: 10.3390/ph17030319.

Tonic endocannabinoid signaling supports sleep through development in both sexes.

Martin S, Gay S, Armstrong M, Pazhayam N, Reisdorph N, Diering G Sleep. 2022; 45(8).

PMID: 35395682 PMC: 9366650. DOI: 10.1093/sleep/zsac083.

References

Kantor S, Jakus R, Bodizs R, Halasz P, Bagdy G . Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift. Brain Res. 2002; 943(1):105-11. DOI: 10.1016/s0006-8993(02)02698-7. View

Kishi A, Struzik Z, Natelson B, Togo F, Yamamoto Y . Dynamics of sleep stage transitions in healthy humans and patients with chronic fatigue syndrome. Am J Physiol Regul Integr Comp Physiol. 2008; 294(6):R1980-7. PMC: 9741833. DOI: 10.1152/ajpregu.00925.2007. View

Simasko S, Mukherjee S . Novel analysis of sleep patterns in rats separates periods of vigilance cycling from long-duration wake events. Behav Brain Res. 2008; 196(2):228-36. PMC: 2617706. DOI: 10.1016/j.bbr.2008.09.003. View

Kitka T, Katai Z, Pap D, Molnar E, Adori C, Bagdy G . Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep rebound. Behav Brain Res. 2009; 205(2):482-7. DOI: 10.1016/j.bbr.2009.08.004. View

Bizzotto R, Zamuner S, De Nicolao G, Karlsson M, Gomeni R . Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients. J Pharmacokinet Pharmacodyn. 2010; 37(2):137-55. DOI: 10.1007/s10928-009-9148-2. View

Diniz Behn C, Klerman E, Mochizuki T, Lin S, Scammell T . Abnormal sleep/wake dynamics in orexin knockout mice. Sleep. 2010; 33(3):297-306. PMC: 2831423. DOI: 10.1093/sleep/33.3.297. View

McShane B, Galante R, Jensen S, Naidoo N, Pack A, Wyner A . Characterization of the bout durations of sleep and wakefulness. J Neurosci Methods. 2010; 193(2):321-33. PMC: 2970733. DOI: 10.1016/j.jneumeth.2010.08.024. View

Klerman E, Wang W, Duffy J, Dijk D, Czeisler C, Kronauer R . Survival analysis indicates that age-related decline in sleep continuity occurs exclusively during NREM sleep. Neurobiol Aging. 2012; 34(1):309-18. PMC: 3469724. DOI: 10.1016/j.neurobiolaging.2012.05.018. View

Goonawardena A, Plano A, Robinson L, Platt B, Hampson R, Riedel G . A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats. Sleep Disord. 2013; 2011:178469. PMC: 3581240. DOI: 10.1155/2011/178469. View

10.

McLaughlin P, Thakur G, Vemuri V, McClure E, Brown C, Winston K . Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054. Pharmacol Biochem Behav. 2013; 109:16-22. PMC: 4015344. DOI: 10.1016/j.pbb.2013.04.011. View

11.

Stephenson R, Famina S, Caron A, Lim J . Statistical properties of sleep-wake behavior in the rat and their relation to circadian and ultradian phases. Sleep. 2013; 36(9):1377-90. PMC: 3738048. DOI: 10.5665/sleep.2970. View

12.

Williamson T, Eliasziw M, Hilton Fick G . Log-binomial models: exploring failed convergence. Emerg Themes Epidemiol. 2013; 10(1):14. PMC: 3909339. DOI: 10.1186/1742-7622-10-14. View

13.

McShane B, Jensen S, Pack A, Wyner A . Statistical Learning with Time Series Dependence: An Application to Scoring Sleep in Mice. J Am Stat Assoc. 2014; 108(504):1147-1162. PMC: 3913289. DOI: 10.1080/01621459.2013.779838. View

14.

Goonawardena A, Plano A, Robinson L, Ross R, Greig I, Pertwee R . Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459. Behav Pharmacol. 2014; 26(3):289-303. PMC: 4445652. DOI: 10.1097/FBP.0000000000000108. View

15.

Kostyalik D, Vas S, Katai Z, Kitka T, Gyertyan I, Bagdy G . Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains. BMC Neurosci. 2014; 15:120. PMC: 4243313. DOI: 10.1186/s12868-014-0120-8. View

16.

Calik M, Carley D . Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats. Sleep. 2017; 40(9). PMC: 5806547. DOI: 10.1093/sleep/zsx112. View

17.

Bizzotto R, Zamuner S . Analysis of variability in length of sleep state bouts reveals memory-free sleep subcomponents consistent among primary insomnia patients. J Neurophysiol. 2018; 119(5):1836-1851. DOI: 10.1152/jn.00649.2017. View

18.

Santucci V, Storme J, Soubrie P, Le Fur G . Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci. 1996; 58(6):PL103-10. DOI: 10.1016/0024-3205(95)02319-4. View

19.

Huber R, Deboer T, Schwierin B, Tobler I . Effect of melatonin on sleep and brain temperature in the Djungarian hamster and the rat. Physiol Behav. 1998; 65(1):77-82. DOI: 10.1016/s0031-9384(98)00125-5. View